الفهرس | Only 14 pages are availabe for public view |
Abstract Patients with LUTS due to BPH who were meeting the study inclusion criteria were randomized between ThuVEP (55 patients) and Green LEP (54 patients). Perioperative variables were reported and compared. Patients were followed at 1, 3 and 6 months postoperative. All functional subjective (symptoms score and quality of life score) and objective outcome parameters (flow rate, residual urine and changes in prostate volume and PSA) were assessed and compared. The primary endpoint was the symptom score at 6 months. Noninferiority of Green LEP in symptom score reduction was tested against ThuVEP. Mean patient age was 67±6.4 and 65.4±6.6 years for ThuVEP and GreenLEP, respectively. The mean preoperative prostate size was 128±34.3 and112.6±28 ml in ThuVEP and GreenLEP groups, respectively. In both groups, the mean± IPSS showed significant improvement at 1,3 and 6 months follow up visits compared to preoperative values (p<0.0001) with no significant differences between both groups. These improvements were evident in both catheterized and non catheterized patients. Improvements were evident in both storage and voiding subdomains. At 12 months, urinary flow parameters improved significantly in both groups compared with the baseline values. Enucleation efficiency was higher in ThuVEP (1 vs 0.76 gm/min, p= 0.001) but GreenLEP was associated with less haemoglobin deficit than ThuVEP (0.8 vs 1.2 gm/dl, p= .026). Blood transfusion was necessary in 2 patients in each group. Endoscopic haemostasis was performed in 2 patients in ThuVEP and 3 patients in GreenLEP group. Unplanned readmission for hematuria within 30 days after surgery was encountered in 2 patients in each group. Three patients were managed conservatively and one patient in ThuVEP group underwent endoscopic haemostasis.Summary & Conclusion -81- The mean ±SD percent reduction of PSA level was 87.7 ±35 % and 79.5±20.6%, P=0.54) in ThuVEP and GreenLEP groups, respectively (table1). Two patients in each group suffered persistent stress incontinence. |